MARVA MITCHELL-SPRUAL: Open Payments
NPI 1164030045 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 9 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $863 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $237 |
| AstraZeneca Pharmaceuticals LP | 2 | $232 |
| Cipher Pharmaceuticals US LLC | 1 | $154 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $142 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| COLOPLAST CORP | 1 | $88 |
Products named: Natroba, DRIZALMA SPRINKLE, ONPATTRO, Descovy, FASENRA, Yeztugo, AUSTEDO XR, Titan.
Industry payments across NJ — which companies pay providers there.
